Dr. Chris Moyses – Chief Medical Officer

Executive Management Team

Dr Chris Moyses is Kind’s Chief Medical Officer and brings a wealth of experience to the medical development, clinical trial and regulatory aspects the firm is engaged in. He was formerly the Chief Executive Officer of NeuroDiscovery Group, a listed Australian company and prior to that Chief Medical Officer of Argenta Discovery, R&D Director of Pharmagene plc and Chief Medical Officer and Executive Director of Oxford GlycoSciences plc with responsibility for all drug development activities. Prior to joining OGS in 1996, he was vice-president of clinical and regulatory affairs (Europe) for Amylin Pharmaceuticals Inc., and previously held posts with G.D. Searle and ICI Pharmaceuticals. He qualified in medicine at the University of Cambridge in 1979 and carried out research in physiology at the University of Oxford.